trans10x10
sitemap  |  sign up  |  contact us  |  privacy policy
Choose Language Here Russian Vietnamese Bahasa
line 01
left shadow background divider
 
 

Sodium Fluoride PET/CT scan

 

With the widespread use of PET/CT scanners and improvement in the technology, Sodium Fluoride-18 (NaF-18) has reemerged as an ideal agent for bone imaging.

Radionuclide bone scanning has been in use for almost four decades now, and has been mainstay for the detection of skeletal metastases in oncology as well as for many benign bone disorders such as stress fractures in orthopaedics. Traditionally the bone scan has been performed with planar imaging using a pharmaceutical such as MDP (methylene diphosphonate) tagged with an isotope like technetium-99m (Tc-99m). After injection into the patient, the tracer incorporates into metabolically active bone, usually at the site of osteoclastic activity. The images are evaluated for "hot spots," or patterns of abnormal bone metabolism likely to indicate malignancy or other pathology like fracture or degenerative changes or Paget's disease.

NaF-18 chemical structureNaF-18 chemical structure

In oncological imaging, the sensitivity and specificity of planar bone scans varies depending upon various factors, but generally the sensitivity ranges between 62% - 100% and the specificity between 78%-100%. Most of the times, the degenerative, post traumatic or postoperative changes in cancer patients, make interpretation of planar bone scans difficult or inconclusive. Addition of SPECT (single photon emission computed tomography) and particularly of SPECT-/CT increases the sensitivity and specificity. However, such an approach increases the scanning time dramatically increases and this extra imaging time is often not attainable either due to very sick patients or those who are in pain, or due to logistics or unavailability of camera time for additional study.

Recently a new pharmaceutical sodium fluoride-18 (NaF-18) has come into day-to-day use. This agent is a positron-emitting isotope and was first used in the early 1960s but was not suitable for imaging with rectilinear scanners and gamma cameras. However, with the introduction of Positron Emitting Tomography (PET) scanners in the 1990s, and especially since the widespread introduction of PET/CT scanners, NaF has reemerged as an ideal agent for bone imaging. With the addition of a co-registered low dose CT, the morphology of a lesion can be easily and accurately characterized.

From the patient's perspective a PET bone scan is more easily tolerated than a planar scan. The waiting time after injection to the actually scan is approximately 45 minutes for PET, compared to 3 hours for a conventional bone scan. The actual time taken for a PET bone scan is usually between 15-20 minutes versus 45-60 minutes with a planar scan or even longer if SPECT is performed as an adjunct to the planar scan. Since, a low dose CT scan accompanies the PET bone scan as a routine part of the examination, the patient usually does not need additional imaging such as plain x rays or MRI to differentiate benign from malignant bone processes. Generally, the radiation dose to the patient from a PET bone scan is slightly less than the traditional bone scan, on modern PET scanners.

From a nuclear medicine's perspective, the PET bone scan has a greater sensitivity and specificity than other nuclear medicine techniques. The higher photon flux with NaF-18 compared to traditional bone scanning agents makes the lesions more conspicuous and easier to see. This translates to detection of relatively higher number of lesions on PET bone scan.

From the oncologist's perspective a PET bone scan offers increased sensitivity of 90 percent and increased specificity of 97 percent. The increase is due to the nature of the isotope and scanner (and also the presence of a co-registered low dose CT scan, allowing accurate anatomic characterization of metabolically active lesions.

Singapore PET and Cardiac imaging Centre is the only diagnostic imaging centre in Singapore, performing currently NaF-18 PET bone scan. NaF-18's higher diagnostic accuracy, shorter study times resulting in improved patient convenience and faster reports make it a suitable replacement of the planar bone scan.

Further reading:

  bullet01 Frederick D Grant et al. Skeletal PET with 18F-Fluroride: Applying new technology to an old tracer. J Nucl Med 2008;49:68-78
  bullet01 Robert L Bridges et al. An introduction to Na18F bone scintigraphy: basic principles, advanced imaging concepts and case examples. J Nucl Med Technol 2007;35:64-76
  bullet01 PShinji Ito et al. Comparison of 18F-FDG PET and bone scintigraphy for in detection of bone metastases of thyroid cancer. J Nucl Med 2007;48:889-895
  bullet01 Einat Even-Sapir et al. The detection of bone metastases in patients with high-risk of prostate cancer: 99mTc-MDP Planar bone scintigraphy, single and multiple field-of-view SPECT, 18F-Fluoride PET and 18F-Fluoride PET/CT. J Nucl Med 2006;47:287-297
  bullet01 Holger Schirrmeister et al. Prospective evaluation of the clinical value of planar bone scans, SPECT and 18F-Labeled NaF in newly diagnosed lung cancer. J Nucl Med 2001;42:1800-1804
 
right shadow
contact side
sitemap   |  contact us   |  privacy policy
2008 - 2012 and Radlink PET and Cardiac Imaging Centre Pte Ltd